Turner Investments’s Enanta Pharmaceuticals ENTA Stock Holding History

Turner Investments’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-26,500	Closed	-$1.35M	–	448
2014 Q4	$1.35M	Sell	26,500 -48,610	-65%	-$2.18M	0.16%	219
2014 Q3	$2.97M	Sell	75,110 -30,040	-29%	-$1.2M	0.18%	172
2014 Q2	$4.53M	Sell	105,150 -15,150	-13%	-$578K	0.2%	147
2014 Q1	$4.81M	Buy	120,300 +24,770	+26%	+$900K	0.13%	207
2013 Q4	$2.61M	Sell	95,530 -8,030	-8%	-$195K	0.05%	350
2013 Q3	$2.37M	Buy	103,560 +14,360	+16%	+$274K	0.04%	386
2013 Q2	$1.58M	Buy	+89,200	New	+$1.74M	0.02%	474

Other funds holding ENTA

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MVM

McClain Value Management New Canaan, Connecticut $50.9M AUM 16.06% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Turner Investments's ENTA Position: Q1 2015 in Review

Turner Investments sold out of Enanta Pharmaceuticals (ENTA) in Q1 2015, closing a stake of 26,500 shares — an estimated $1.35M sold.

Turner Investments first reported a position in ENTA in Q2 2013 and held it in 7 quarters. The position peaked at $4.81M in Q1 2014. 117 funds tracked by Wall St. Rank hold ENTA as of Q1 2015.

Turner Investments reported no remaining Enanta Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
Turner Investments sold 26,500 Enanta Pharmaceuticals shares in Q1 2015, an estimated $1.35M.
Turner Investments first reported a position in Enanta Pharmaceuticals in Q2 2013 and held it in 7 quarters.
Turner Investments's Enanta Pharmaceuticals position peaked at $4.81M in Q1 2014.
117 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2015.

Based on Turner Investments's 13F filing for Q1 2015, filed 12 May 2015.